Podcast - Biopharmaceutical Manufacturing in India: The Challenges - - BioPharm International

ADVERTISEMENT

Podcast - Biopharmaceutical Manufacturing in India: The Challenges




Ajit Mahadevan
Leader of Biotech initiatives for the India Life Sciences Practices at Ernst & Young

Add this Podcast feed to your media player



Faced with economic pressures and budget constraints, biopharmaceutical companies are increasingly looking at outsourcing as a cost-effective alternative. In this interview, Ajit Mahadevan, Leader of Biotech initiatives for the India Life Sciences Practices at Ernst & Young, discusses current trends and challenges of outsourcing biomanufacturing-related activities to India.

Click here to go to the main podcast page >>>


Related Links:
India Today by Eric Langer
Outsourcing Insights by Jim Miller
Perspectives on Outsourcing
blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here